Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 110 points (-0.7%) at 16,401 as of Tuesday, May 20, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 820 issues advancing vs. 2,151 declining with 156 unchanged. The Financial sector currently sits down 0.6% versus the S&P 500, which is down 0.6%. On the negative front, top decliners within the sector include Orix ( IX), down 3.3%, Mitsubishi UFJ Financial Group ( MTU), down 2.5%, Affiliated Managers Group ( AMG), down 2.3%, CME Group ( CME), down 1.8% and Shinhan Financial Group ( SHG), down 1.7%. Top gainers within the sector include E-House China Holdings ( EJ), up 14.1%, Woori Finance Holdings ( WF), up 1.6%, Grupo Financiero Santander Mexico SAB de CV ( BSMX), up 0.9%, Credit Suisse Group ( CS), up 0.9% and Lloyds Banking Group ( LYG), up 0.6%. TheStreet would like to highlight 3 stocks pushing the sector lower today: 3. MetLife ( MET) is one of the companies pushing the Financial sector lower today. As of noon trading, MetLife is down $0.41 (-0.8%) to $49.51 on light volume. Thus far, 1.9 million shares of MetLife exchanged hands as compared to its average daily volume of 6.4 million shares. The stock has ranged in price between $49.36-$49.95 after having opened the day at $49.84 as compared to the previous trading day's close of $49.92. MetLife, Inc., through its subsidiaries, provides insurance, annuities, and employee benefit programs in the United States, Japan, Latin America, Asia, Europe, and the Middle East. MetLife has a market cap of $55.6 billion and is part of the insurance industry. Shares are down 7.4% year-to-date as of the close of trading on Monday. Currently there are 14 analysts that rate MetLife a buy, no analysts rate it a sell, and 2 rate it a hold. TheStreet Ratings rates MetLife as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, solid stock price performance, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full MetLife Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.